$FIEE

FiEE, Inc. (FIEE): Entry into a Material Definitive Agreement

FiEE, Inc. (FIEE) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 3 fiee_ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 fiee, INC. COMMON STOCK SALES AGREEMENT June 23, 2026 A.G.P./Alliance Global Partners 590 Madison Avenue, 28 th Floor New York, NY 10022 Ladies and Gentlemen: FiEE, Inc., a Delaware corporation (the “ Company ”), confirms its ag

Original reporting
Published Jun 23, 2026, 9:20 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 23, 2026, 9:22 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$FIEE
Bearish
medium confidence
Mentioned
$FIEE
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$FIEEBearishMed
01

Why it matters

The agreement allows FiEE to issue and sell common stock from time to time through a sales agent, typically creating an expected dilution overhang until actual sales/pricing are known.

02

Market read

Traders may reassess dilution risk and near-term supply expectations following the new ATM authorization.

03

What to watch

The agreement’s terms (commission/discount, any volume limits, and whether/when placements actually occur) are not fully shown in the excerpt; actual dilution impact depends on subsequent prospectus supplements and sale notices.

Relevance 6/10Novelty 6/10Timing: after-hours/filing today (8-K filed 2026-06-23)

Background

The 8-K discloses FiEE’s entry into a material definitive agreement for an ATM-style common stock sales program under an effective Form S-3 shelf registration.

Company-level read

Ticker impact

$FIEEBearishMedium confidence
Context

FiEE entered an ATM/common stock sales agreement with A.G.P./Alliance Global Partners, enabling it to issue and sell shares from time to time.

Expected impact

Near-term bias could be downward or volatile on dilution expectations, with realized impact depending on actual share sale pace and pricing.

Evidence & confidence

An ATM/sales agreement is a direct capital-markets action; while the agreement itself doesn’t state sale size or timing, it creates an overhang that traders typically price in ahead of any actual issuances.

Market effects

Adds to the broader read-through that small/mid-cap issuers may use ATMs for liquidity, which can affect sentiment toward similar capital-needs names.

Primarily US small-cap sentiment; limited direct regional spillover implied by the filing.

Low global relevance; this is a company-specific financing mechanism.

Counterpoint

If FiEE uses the ATM opportunistically at favorable prices (or for specific accretive purposes), the overhang may fade quickly and the stock may stabilize.

Key entities

  • FiEE, Inc.

    Company entering the common stock sales agreement (ATM) enabling periodic share issuance.

  • A.G.P./Alliance Global Partners

    Sales agent through which FiEE may sell shares under the agreement.

  • SEC Form S-3 (File No. 333-295474)

    Shelf registration statement referenced as the basis for the ATM issuance.

Related articles

$FIEELow

FiEE, Inc. (FIEE): Results of Operations and Financial Condition

FiEE, Inc. (FIEE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-3.1 2 fiee_ex3-1.htm EXHIBIT 3.1 Exhibit 3.1 THIRD AMENDED AND RESTATED BYLAWS OF FIEE, INC. (A Delaware corporation) ARTICLE I STOCKHOLDERS Section 1.1 Annual Meeting. The annual meeting of the stockholders of FiEE, Inc. (the “Corporation”) shall be held on such date as shall

$ATNMMed

Actinium Pharmaceuticals Announces Actimab-A Intellectual Property and Manufacturing Advances and Provides NYSE American Listing Update

Actinium Pharmaceuticals (NYSE American: ATNM) said it expanded Actimab-A intellectual property with multiple newly issued US patents and additional pre-grant/allowed applications, covering uses in AML, MDS, and solid tumors, including combinations with venetoclax and CLAG-M. The company also amended its IND to add a manufacturing source and reported NYSE American listing compliance plan acceptance through Nov. 27, 2027.

$GOOGMed

Alphabet Just Borrowed $25 Billion, and $2.5 Billion of It Isn't Due Until 2066

Alphabet (GOOG, GOOGL) closed a $25 billion senior notes sale with 10 tranches maturing from 2028 to 2066, including $2.5 billion at 6.5% due Aug 2066. Alphabet said proceeds will go to general corporate purposes, possibly debt repayment. The company raised capex guidance to $195-$205 billion for 2026, pushing long-term debt to about $123 billion by June 30.

$TSNMed

Tyson to sell WA beef plant, close facilities in Illinois, Utah

Tyson Foods said it will seek a buyer for its Pasco, Washington beef plant and close its meat processing facilities in Joslin, Illinois and Eagle Mountain, Utah, citing a cattle shortage. Tyson will consolidate beef packing at plants in Nebraska, Kansas and Texas and add a second shift in Amarillo, Texas. The Justice Department is probing antitrust activity involving Tyson, JBS, Cargill and National Beef.